Metastatic bladder cancer immunotherapy outcomes better with antihistamines
Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using antihistamines in patients receiving second-line immunotherapy (IO) for bladder cancer may improve outcomes.
The research, published in the journal Urologic Oncology, focused on metastatic urothelial carcinoma (mUC), cancer that begins in the urothelial cells, which line the urethra, bladder, ureters and some other organs. Martini, University of Cincinnati Cancer Center physician-researcher and assistant professor in the Department of Urology in UC's College of Medicine, served as corresponding author of the study.
Using data from two clinical trials, the researchers identified 896 patients who were treated with second-line IO drug atezolizumab. Out of those patients, 155 patients received concomitant antihistamines and 741 did not.
Antihistamine users had 41% lower risk for all-cause mortality, 42% lower risk for cancer death and 30% lower risk of cancer progression compared to patients that did not receive antihistamines.
“Our results show a positive association between the use of antihistamines and oncologic outcome in patients with mUC treated with IO,” Martini and colleagues concluded.
Read the Renal + Urology News story.
Featured photo at top of urothelial carcinoma cells stained purple. Photo/OGPhoto/iStock.
Latest UC News
- LinkedIn leader shares tips on getting a job as a college studentMitchell Phelps, enterprise account director at LinkedIn, came to UC’s 1819 Innovation Hub and offered insights on using LinkedIn to launch a professional career while in college.
- Breaking the cycle: Lindner finance student aims to inspire othersLandyn Hopper has spent his life defying the odds. Poverty and homelessness dotted his childhood in and around Dayton, Kentucky. Drugs and gang activity were ever-present. Hopper’s parents, neither of whom finished high school, divorced when he was in grade school. His first job was at age 14.
- President Pinto shares recent DEI developmentsPresident Pinto shares recent DEI developments
- Chlorine plus UV light can detoxify water affected by harmful algae bloomsScience and engineering outlets write about research by the University of Cincinnati examining cost-effective ways to protect drinking water from harmful algal blooms.
- CCM alumni advance to Met Opera's Laffont Competition SemifinalsThe Metropolitan Opera Eric and Dominique Laffont Competition, one of the most prestigious singing competitions in the world, recently announced the full list of its national semifinalists. Of the 20 semifinalists, 5 of the singers hold degrees from the UC College-Conservatory of Music.
- Why are fighter planes so loud?SlashGear talks to UC College of Engineering and Applied Science Distinguished Research Professor Ephraim Gutmark about his efforts to dampen the noise of jet engines in his aerospace engineering lab.
